These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24328365)

  • 1. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.
    Kombo DC; Bencherif M
    J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs).
    Kombo DC; Grinevich VP; Hauser TA; Sidach S; Bencherif M
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4842-7. PubMed ID: 23886687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes.
    Kombo DC; Mazurov AA; Strachan JP; Bencherif M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5105-13. PubMed ID: 23937977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.
    Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
    Peng W; Ding F
    Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease.
    Chen SG; Gu RX; Dai H; Wei DQ
    J Mol Graph Model; 2013 Feb; 39():98-107. PubMed ID: 23261879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
    Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
    Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine.
    Hauser TA; Hepler CD; Kombo DC; Grinevich VP; Kiser MN; Hooker DN; Zhang J; Mountfort D; Selwood A; Akireddy SR; Letchworth SR; Yohannes D
    Neuropharmacology; 2012 Jun; 62(7):2239-50. PubMed ID: 22306792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR).
    Kombo DC; Hauser TA; Grinevich VP; Melvin MS; Strachan JP; Sidach SS; Chewning J; Fedorov N; Tallapragada K; Breining SR; Miller CH
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1450-5. PubMed ID: 23352509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors.
    Yuan H; Petukhov PA
    Bioorg Med Chem; 2006 Dec; 14(23):7936-42. PubMed ID: 16919961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking to flexible nicotinic acetylcholine receptors: a validation study using the acetylcholine binding protein.
    Sander T; Bruun AT; Balle T
    J Mol Graph Model; 2010 Nov; 29(3):415-24. PubMed ID: 20884263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
    Bisson WH; Scapozza L; Westera G; Mu L; Schubiger PA
    J Med Chem; 2005 Aug; 48(16):5123-30. PubMed ID: 16078832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptors.
    Hopping G; Wang CI; Hogg RC; Nevin ST; Lewis RJ; Adams DJ; Alewood PF
    Biochem Pharmacol; 2014 Oct; 91(4):534-42. PubMed ID: 25101833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
    Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
    J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptors.
    Faundez-Parraguez M; Farias-Rabelo N; Gonzalez-Gutierrez JP; Etcheverry-Berrios A; Alzate-Morales J; Adasme-Carreño F; Varas R; Bermudez I; Iturriaga-Vasquez P
    Bioorg Med Chem; 2013 May; 21(10):2687-94. PubMed ID: 23561269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.